Close



Aug 2, 2023 04:01PM
Aug 2, 2023 04:01PM
Jul 28, 2023 07:05AM
Jul 14, 2023 07:05AM
Jun 13, 2023 04:05PM
Jun 5, 2023 04:05PM
May 25, 2023 05:00PM Aravive to Present Promising Updated Data from Phase 2 Trial of Batiraxcept in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma at ASCO 2023
May 16, 2023 07:05AM
May 16, 2023 07:05AM
May 10, 2023 04:05PM
May 8, 2023 07:05AM
Apr 26, 2023 05:00PM
Apr 11, 2023 07:05AM
Apr 11, 2023 07:05AM Aravive Appoints Carolina Petrini as Chief Commercial Officer
Mar 15, 2023 07:00AM
Feb 28, 2023 04:05PM
Feb 13, 2023 05:00PM
Jan 4, 2023 07:05AM
Nov 29, 2022 07:04AM
Nov 29, 2022 07:00AM
Nov 21, 2022 07:00AM Aravive To Participate in Piper’s 34th Annual Healthcare Conference
Nov 16, 2022 07:02AM
Nov 16, 2022 07:00AM
Nov 10, 2022 07:00AM
Oct 25, 2022 07:32AM
Oct 25, 2022 07:30AM
Oct 10, 2022 04:05PM
Sep 26, 2022 08:00AM Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference
Sep 6, 2022 04:05PM
Aug 11, 2022 07:00AM
Jul 5, 2022 09:07AM
Jul 5, 2022 09:07AM
Jun 3, 2022 07:02AM
Jun 3, 2022 07:00AM
May 26, 2022 05:11PM Aravive Presents Updated Clinical Data at ASCO Showing Continued Best-in-Class Potential of Batiraxcept in Advanced or Metastatic clear cell Renal Cell Carcinoma (ccRCC)
May 17, 2022 07:00AM
May 12, 2022 07:00AM
May 5, 2022 07:00AM
Apr 29, 2022 07:00AM
Apr 1, 2022 07:00AM
Mar 31, 2022 04:05PM
Mar 30, 2022 08:01AM Aravive Inc. (ARAV) Prices 4.85M Share and Warrant Direct Offering
Mar 30, 2022 08:00AM
Mar 22, 2022 07:02AM
Mar 22, 2022 07:00AM
Mar 7, 2022 07:00AM
Mar 3, 2022 07:10AM
Mar 3, 2022 07:00AM
Mar 2, 2022 07:00AM Aravive to Present Updated Modeling Data from Batiraxcept Clinical Trials at the AACR Annual Meeting
Jan 31, 2022 07:00AM

251,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All